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Identity 
Other names: PRAD1 (parathyroid adenomatosis 1) 
Location: 11q13 
 









The gene encodes the cyclin D1; 295 amino acids; 36 
kDa. 
Expression 
No normal expression in lymphocytes; cell cycle 
dependant expression: maximal expression in G1, 




Cell cycle control: G1 progression and G1/S transition; 
forms complexes with CDK4 and 6, and further with 
RB1; phosphorylation of RB1 by cyclin D1/CDK4 
removes the cell cycle arrestin G1/S start point; 
inhibited by P21, P15, and P16. 
Homology 
With other cyclins. 
Implicated in 
t(11;14)(q13;q32)/B-cell malignancies 
→ BCL1 - IgH 
Disease 
t(11;14) is mainly found in mantle cell lymphoma; also 
in: B-prolymphocytic leukaemia, plasma cell 
leukaemia, splenic lymphoma with villous 
lymphocytes; rarely in: chronic lymphocytic leukaemia, 
multiple myeloma. 
Prognosis 




5' BCL1 translocated on chromosome 14 near JH 
(junctions genes of IgH) and C in 3'. 
Abnormal Protein 
No fusion protein, but promoter exchange; the 
immunoglobulin gene enhancer stimulates the 
expression of BCL1. 
Oncogenesis 
Overexpression of BCL1 accelerates the cell transit 
through the G1 phase. 
Parathyroid adenomatosis 
Hybrid/Mutated Gene 
With PTH, the parathyroid hormone gene, sitting in 
11p15. 
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